PIK3CA and glioblastoma: In a completely similar study by these researchers, inhibiting PI3K isoforms via CRISPR/Cas9 in mice with glioblastoma has confirmed that the inhibition of the PI3K-α isoform leads to an enhancement of radiosensitivity, thereby causing a reduction in tumor growth and an extension of survival (24).